Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: December 17, 2009
Event: Amendments to the Company's Bylaws.
Financial Metrics
This filing does not contain financial data. The document reports on corporate governance changes rather than financial performance. Consequently, there are no values provided for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The Board of Directors amended the Bylaws on December 17, 2009, primarily to address two areas:
- Record Dates: Bylaw 50 was amended to align with Section 213 of the Delaware General Corporation Law. This allows the Board to fix one record date for stockholders entitled to receive notice of a meeting and a separate, later record date for stockholders entitled to vote.
- Officer Appointments: Bylaws 29, 38, and 39 were amended to permit the Secretary and Treasurer to appoint Assistant Secretaries and Assistant Treasurers, respectively.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the adoption of revised Bylaws.
Key Facts for Investor Verification
- Verify the effective date of the Bylaw amendments (December 17, 2009).
- Confirm the specific changes to Bylaw 50 regarding the separation of record dates for notice and voting.
- Review the attached Exhibit 3.1 for the full text of the revised Bylaws.
- Note that this filing does not impact the company's financial statements or operational results.